TrialScientific reports2021
The feasibility of Gazefinder under 12 months of age infants.
Shuntaro Fukushima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
TrialScientific reports2021
Shuntaro Fukushima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.